Heart rate variability - a therapeutic target?
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Reduced heart rate variability (HRV) is a powerful and independent predictor of an adverse prognosis in patients with heart disease and in the general population. The HRV is largely determined by vagally mediated beat to beat variability, conventionally known as respiratory sinus arrhythmia. Thus, HRV is primarily an indicator of cardiac vagal control. It is still unclear whether the relationship between measures of cardiac vagal control and mortality is causative or mere association. Possible mechanisms by which cardiac vagal activity might beneficially influence prognosis include a decrease in myocardial oxygen demand, a reduction in sympathetic activity and a decreased susceptibility of the ventricular myocardium to lethal arrhythmia. In animals, augmentation of cardiac vagal control by nerve stimulation or by drugs is associated with a reduction in sudden death in susceptible models. In humans a number of drugs which have been shown to reduce mortality and sudden death in large randomised trials can also be demonstrated to increase HRV. As a result of this evidence, it has been suggested that the effect of drugs or other therapeutic manoeuvres on HRV might be used to predict clinical efficacy. The use of HRV as a therapeutic target is discussed in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Cohn, J. N., Johnson, G., Ziesche, S., Cobb, F., Francis, G., Tristani, F., Smith, R., Dunkman, W. B., Loeb, H., Wong, M., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250502 · Cited by 2,833
Impact of Reduced Heart Rate Variability on Risk for Cardiac Events: The Framingham Heart Study
Tsuji, H., Larson, M. G., Venditti, F. J., Manders, E. S., Evans, J. C., Feldman, C. L., & Levy, D. (1996) · Circulation · doi:10.1161/01.cir.94.11.2850 · Cited by 1,762
Respiratory sinus arrhythmia: noninvasive measure of parasympathetic cardiac control
Katona, P. G., & Jih, F. (1975) · Journal of Applied Physiology · doi:10.1152/jappl.1975.39.5.801 · Cited by 792
Vanoli, E., De Ferrari, G. M., Stramba-Badiale, M., Hull, S. S., Foreman, R. D., & Schwartz, P. J. (1991) · Circulation Research · doi:10.1161/01.res.68.5.1471 · Cited by 681
Human sinus arrhythmia as an index of vagal cardiac outflow.
Eckberg, D. L. (1983) · Journal of Applied Physiology · doi:10.1152/jappl.1983.54.4.961 · Cited by 633
Hull, S. S., Vanoli, E., Adamson, P. B., Verrier, R. L., Foreman, R. D., & Schwartz, P. J. (1994) · Circulation · doi:10.1161/01.cir.89.2.548 · Cited by 299 · cited 1×
“In an experimental dog model, 6 weeks of treadmill training not only increased HRV and BRS but was also associated with complete prevention of VF during exercise/ischaemia (65).”
Method
Cited by
The role of vagal function in the risk for cardiovascular disease and mortality
Thayer, J. F., & Lane, R. D. (2007) · Biological Psychology · doi:10.1016/j.biopsycho.2005.11.013 · Cited by 1,033
Validity of (ultra-)short recordings for heart rate variability measurements.
Munoz, M. L., van Roon, A., Riese, H., Thio, C., Oostenbroek, E., Westrik, I., de Geus, E. J. C., Gansevoort, R., Lefrandt, J., Nolte, I. M., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138921 · Cited by 423
“Heart rate variability (HRV) quantifies beat-to-beat fluctuations in heart rate and is considered an index of cardiac parasympathetic nervous system activity [1–3].”
BackgroundThe reliability of short-term measurements of heart rate variability
Sandercock, G. R. H., Bromley, P. D., & Brodie, D. A. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.09.013 · Cited by 307
Methods of assessing vagus nerve activity and reflexes
Chapleau, M. W., & Sabharwal, R. (2011) · Heart Failure Reviews · doi:10.1007/s10741-010-9174-6 · Cited by 182
Vagal regulation, cortisol, and sleep disruption in women with metastatic breast cancer
Palesh, O., Zeitzer, J. M., Conrad, A., Giese-Davis, J., Mustian, K. M., Popek, V., Nga, K., & Spiegel, D. (2008) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27280 · Cited by 87
Metadata
- Authors
- Routledge, H. C., Chowdhary, S., & Townend, J. N.
- Venue
- Journal of Clinical Pharmacy and Therapeutics
- Publisher
- Hindawi Limited
- Published
- 2002-04
- Volume
- 27
- Issue
- 2
- Pages
- 85-92
- ISSN
- 0269-4727 (ISSN-L)
- 1365-2710
- OpenAlex
- W2104883150
- Cited by
- 120
- References
- 7
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Heart rate variability - a therapeutic target? https://app.cochat.ai/papers/10.1046/j.1365-2710.2002.00404.x
- The paper
- Routledge, H. C., Chowdhary, S., & Townend, J. N. (2002). Heart rate variability - a therapeutic target? Journal of Clinical Pharmacy and Therapeutics. https://doi.org/10.1046/j.1365-2710.2002.00404.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.